Click here to return to the Reference Table

Category: Hematopoietic Malignancies
Cancer type: Lymphomas
Descriptor: Reviews

Reference Number: 887
Mahtouk K, Tjin EP, Spaargaren M, Pals ST. The HGF/MET pathway as target for the treatment of multiple myeloma and B-cell lymphomas. Biochim Biophys Acta. 1806, 208-19 (2010)
PubMed link      E-mail link

Reference Number: 958
Rodig SJ, Shapiro GI. Crizotinib, a small-molecule dual inhibitor of the c-Met and ALK receptor tyrosine kinases. Curr Opin Investig Drugs. 11, 1477-90 (2010)
PubMed link      E-mail link